This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Demetris, A. J. Articles by Dekker, A. Search for Related Content PubMed PubMed Citation Articles by Demetris, A. J. Articles by Dekker, A.

American Journal of Pathology, Vol 118, 151-161, Copyright © 1985 by American Society for Investigative Pathology

REGULAR ARTICLES

Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen

AJ Demetris, S Lasky, DH Van Thiel, TE Starzl and A Dekker

The pathologic specimens (n = 118) and hospital course pertinent to each of 62 adult liver allograft recipients were reviewed. Biopsies and retransplanted organs were obtained at the discretion of the surgical team on the basis of the postoperative clinical course (less than 1 day to greater than 12 years after transplantation), and final interpretation of the pathologic material was based on a correlation of all available data. Most of the specimens (n = 85) were obtained within the first 2 months, and diagnoses in this time period included rejection, biliary obstruction/cholangitis, vascular injury, herpesvirus and cytomegalovirus hepatitis, graft necrosis, and functional cholestasis. Thereafter, rejection and recurrent or primary viral hepatitis were the major causes of graft dysfunction. Histologically, hepatic rejection is manifested by a cellular mediated injury of hepatocytes and bile ductules and a spectrum of vascular lesions in medium-sized hilar arteries. Morphologic changes of biliary duct obstruction and viral liver disease were at times difficult to differentiate from rejection. Two pretransplant disorders, type B viral hepatitis and the Budd-Chiari syndrome, recurred in grafted organs. Although interpretation of pathologic material may be difficult at times, it frequently is helpful in planning an approach to management of liver allograft recipients.

This article has been cited by other articles:

				M. Sata, Z. Luo, and K. Walsh Fas Ligand Overexpression on Allograft Endothelium Inhibits Inflammatory Cell Infiltration and Transplant-Associated Intimal Hyperplasia J. Immunol., June 1, 2001; 166(11): 6964 - 6971. [Abstract] [Full Text] [PDF]

				X. Bai, B. B. Rogers, P. C. Harkins, J. Sommerauer, R. Squires, K. Rotondo, A. Quan, D. B. Dawson, and R. H. Scheuermann Predictive Value of Quantitative PCR-Based Viral Burden Analysis for Eight Human Herpesviruses in Pediatric Solid Organ Transplant Patients J. Mol. Diagn., November 1, 2000; 2(4): 191 - 201. [Abstract] [Full Text]

				K. B. Lemstrom, A. K. Raisanen-Sokolowski, P. J. Hayry, and P. K. Koskinen Triple Drug Immunosuppression Significantly Reduces Aortic Allograft Arteriosclerosis in the Rat Arterioscler. Thromb. Vasc. Biol., April 1, 1996; 16(4): 553 - 564. [Abstract] [Full Text]

				E. A. DelBuono, H. D. Appelman, and T. S. Frank Role of Polymerase Chain Reaction in the Diagnosis of Cytomegalovirus Infection in Liver Transplant Patients International Journal of Surgical Pathology, January 1, 1995; 2(3): 221 - 226. [Abstract] [PDF]